- On October 12, the Trump administration announced it would stop making cost-sharing reduction payments to insurers, because it lacked a constitutionally valid appropriation to do so—an action that restores Congress’ “power of the purse.”
- While some have proposed that Congress should appropriate funds for the payments, such action would effectively reward insurers’ prior risky behavior—assuming cost-sharing reductions would continue to be paid, even after a federal judge struck them down as unconstitutional—thereby perpetuating moral hazard.
- A better course of action is repealing the undermining regulations surrounding Obamacare, which necessitated the unconstitutional cost-sharing reduction payments to insurers in the first place.
Restoring Common Sense to Healthcare
Who determines whether a drug is covered by insurance? Or if a drug is a “specialty drug”? Who puts the price on drugs? You might think it would be the drug manufacturers or pharmacies that determine these things. However, another entity has overstepped and is making a profit off of the system while patients are...